短帚霉，一种对广谱抗真菌剂耐药的真菌病原体。
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
作者信息
Cuenca-Estrella Manuel, Gomez-Lopez Alicia, Mellado Emilia, Buitrago Maria J, Monzón Araceli, Rodriguez-Tudela Juan L
机构信息
Unidad de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.
出版信息
Antimicrob Agents Chemother. 2003 Jul;47(7):2339-41. doi: 10.1128/AAC.47.7.2339-2341.2003.
Abstract
The antifungal susceptibility results for 32 clinical isolates of Scopulariopsis brevicaulis are presented. Flucytosine and itraconazole were inactive in vitro, and MICs of amphotericin B, voriconazole, and terbinafine for all isolates were high, with geometric means of 13, 25.8, and 14.4 microg/ml, respectively.
摘要
本文展示了32株短帚霉临床分离株的抗真菌药敏结果。氟胞嘧啶和伊曲康唑在体外无活性，所有分离株对两性霉素B、伏立康唑和特比萘芬的最低抑菌浓度（MIC）均较高，几何平均值分别为13、25.8和14.4微克/毫升。
相似文献
1
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Antimicrob Agents Chemother. 2003 Jul;47(7):2339-41. doi: 10.1128/AAC.47.7.2339-2341.2003.
2
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Antimicrob Agents Chemother. 2006 Jun;50(6):2248-50. doi: 10.1128/AAC.00162-06.
3
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Antimicrob Agents Chemother. 2011 Sep;55(9):4485-7. doi: 10.1128/AAC.01015-10. Epub 2011 Jun 20.
4
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Antimicrob Agents Chemother. 2006 Mar;50(3):917-21. doi: 10.1128/AAC.50.3.917-921.2006.
5
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Antimicrob Agents Chemother. 2015 Sep;59(9):5827-9. doi: 10.1128/AAC.00978-15. Epub 2015 Jun 22.
6
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Antimicrob Agents Chemother. 2006 Dec;50(12):4211-3. doi: 10.1128/AAC.00981-06. Epub 2006 Oct 2.
7
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
J Antimicrob Chemother. 2001 Dec;48(6):919-21. doi: 10.1093/jac/48.6.919.
8
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Antimicrob Agents Chemother. 2012 Nov;56(11):6044-7. doi: 10.1128/AAC.01112-12. Epub 2012 Sep 4.
9
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Med Mycol. 2009 Mar;47(2):169-76. doi: 10.1080/13693780802213407. Epub 2008 Jul 24.
10
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Diagn Microbiol Infect Dis. 2004 Jan;48(1):69-71. doi: 10.1016/j.diagmicrobio.2003.09.003.
引用本文的文献
1
[Scopulariopsis brevicaulis : The "arsenic fungus"-a difficult-to-treat pathogen].
Dermatologie (Heidelb). 2025 Jun 25. doi: 10.1007/s00105-025-05526-9.
2
Understanding the role of bats as fungal vectors in the environment.
IMA Fungus. 2024 Sep 4;15(1):28. doi: 10.1186/s43008-024-00161-w.
3
Native Aortic Valve Endocarditis Caused by Species: Case Report, Considerations for Management, and Review of Literature.
Open Forum Infect Dis. 2024 Jun 14;11(7):ofae323. doi: 10.1093/ofid/ofae323. eCollection 2024 Jul.
4
Microsurgical Debridement for Persistent Ulcers Due to Rare Fungus Infection: Case Report and Literature Review.
Arch Plast Surg. 2024 Feb 7;51(1):135-138. doi: 10.1055/a-2166-8413. eCollection 2024 Jan.
5
Shifting from Ammonium to Phosphonium Salts: A Promising Strategy to Develop Next-Generation Weapons against Biofilms.
Pharmaceutics. 2024 Jan 5;16(1):80. doi: 10.3390/pharmaceutics16010080.
6
A cross-sectional study on occupational exposure to microorganisms, endotoxin, hydrogen sulfide, and dust during work at drilling waste treatment plants.
Ann Work Expo Health. 2024 Jan 8;68(1):58-77. doi: 10.1093/annweh/wxad069.
7
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.
Clin Microbiol Rev. 2023 Sep 21;36(3):e0001923. doi: 10.1128/cmr.00019-23. Epub 2023 Jul 13.
8
Preliminary Studies on the Mechanism of Antifungal Activity of New Cationic β-Glucan Derivatives Obtained from Oats and Barley.
ACS Omega. 2022 Oct 27;7(44):40333-40343. doi: 10.1021/acsomega.2c05311. eCollection 2022 Nov 8.
9
Prevention and Eradication of Biofilm by Dendrimers: A Possibility Still Little Explored.
Pharmaceutics. 2022 Sep 22;14(10):2016. doi: 10.3390/pharmaceutics14102016.
10
"Salt mummification" - atypical method of embalming a corpse.
Int J Legal Med. 2022 Nov;136(6):1829-1840. doi: 10.1007/s00414-022-02855-5. Epub 2022 Jun 24.
本文引用的文献
1
Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.
J Antimicrob Chemother. 2002 Nov;50(5):719-22. doi: 10.1093/jac/dkf187.
2
Scopulariopsis fungus ball.
Ann Thorac Surg. 2002 Sep;74(3):926-7. doi: 10.1016/s0003-4975(02)03684-6.
3
Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient.
Clin Infect Dis. 2000 May;30(5):820-3. doi: 10.1086/313764.
4
In vitro antifungal susceptibilities of Scopulariopsis isolates.
Antimicrob Agents Chemother. 1999 Jun;43(6):1520-2. doi: 10.1128/AAC.43.6.1520.
5
In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens.
Antimicrob Agents Chemother. 1999 May;43(5):1260-3. doi: 10.1128/AAC.43.5.1260.
6
In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin.
Mycoses. 1998 Sep-Oct;41(7-8):309-19. doi: 10.1111/j.1439-0507.1998.tb00344.x.
7
Granulomatous skin infection caused by Scopulariopsis brevicaulis.
J Am Acad Dermatol. 1998 Aug;39(2 Pt 2):365-7. doi: 10.1016/s0190-9622(98)70392-5.
8
Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.
J Antimicrob Chemother. 1997 Sep;40(3):401-14. doi: 10.1093/jac/40.3.401.
9
Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis.
Retina. 1997;17(3):256-8. doi: 10.1097/00006982-199705000-00015.
10
Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
Br J Dermatol. 1996 Nov;135(5):799-802. doi: 10.1111/j.1365-2133.1996.tb03895.x.
Zotero 插件